March 5, 2018 – We are thrilled! Out of 13 companies that pitched at UCLA, Deton was chosen as the Winner of the Audience Choice Award. The audience included judges from Illumina Ventures, Johnson & Johnson, Becton Dickinson, Amgen, W.L. Gore, Bristol Capital Advisors, venture capital firms, and local angel groups. Deton advanced to the main event through a 1 min elevator pitch. During the 5 min pitch followed by a Q & A Deton convinced the judges and audience to go on and win the Audience Choice Award. More than 70 companies were screened to be part of the 2018 Medtech Innovator Los Angeles Pitch Event and more than 700 companies applied to be part of the Medtech Innovator’s global competition and accelerator program.
Deton is decoding lung health using our Aerosol Biopsy solution. Our mission is to transform the understanding of lung disease by providing complete and timely information for treatment decisions as well as research and therapeutics development. Our Aerosol Biopsy solution captures aerosol droplets that originate in the lungs and are expelled during cough and then extracts the genetic information contained within them. Unlike current methods, the Aerosol Biopsy method is non-invasive, accurate and reliable.
About MedTech Innovator
MedTech Innovator is the industry’s nonprofit global competition and accelerator for medical device, digital health and diagnostic companies. MedTech Innovator’s mission is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system.
To learn more about MedTech Innovator, visit https://medtechinnovator.org/ and follow@MedTechAwards on Twitter.